Vern Kornelsen - Encision Independent Director

ECIADelisted Stock  USD 0.44  0.00  0.00%   

Director

Mr. Vern D. Kornelsen serves as an Independent Director of Encision Inc. He is one of Company cofounders and served on Company board of directors and as Company Chief Financial Officer from 1991 through February 1997. He was reelected to the board of directors in April 1998. Mr. Kornelsen is the General Partner of CMED Partners LLLP, one of principal shareholders. Mr. Kornelsen formerly practiced as a certified public accountant in the state of Colorado for many years. He was active in managing two investment partnerships, the first since 1990 and the second since 1997, of which he is the general partner, as well as serving as an officer and director of several private companies and of one public company, Lifeloc Technologies, Inc., of which he is the controlling stockholder since 1998.
Age 90
Tenure 26 years
Phone303 444 2600
Webhttps://www.encision.com
Kornelsen received a BS degree in business from the University of Kansas.

Encision Management Efficiency

The company has return on total asset (ROA) of (0.0831) % which means that it has lost $0.0831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2203) %, meaning that it created substantial loss on money invested by shareholders. Encision's management efficiency ratios could be used to measure how well Encision manages its routine affairs as well as how well it operates its assets and liabilities.
Encision currently holds 206 K in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Encision has a current ratio of 3.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Encision until it has trouble settling it off, either with new capital or with free cash flow. So, Encision's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Encision sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Encision to invest in growth at high rates of return. When we think about Encision's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

DIRECTOR Age

James AndersonProcyon
53
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado. Encision operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 31 people. Encision [ECIA] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). Encision is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

Encision Leadership Team

Elected by the shareholders, the Encision's board of directors comprises two types of representatives: Encision inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Encision. The board's role is to monitor Encision's management team and ensure that shareholders' interests are well served. Encision's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Encision's outside directors are responsible for providing unbiased perspectives on the board's policies.
Peter Geary, Vice President - Operations
Mala Ray, Controller, Treasurer and Corporate Secretary
Gregory Trudel, CEO and President and Director
Brian Jackman, VP Marketing
Robert Fries, Independent Director
David Newton, Co-Founder, VP of Technology and Director
Vern Kornelsen, Independent Director

Encision Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Encision a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in Encision Pink Sheet

If you are still planning to invest in Encision check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Encision's history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon